Close Menu

Still Not a Bad Sum

Senior officials at Massachusetts General and Brigham and Women's Hospitals are restricted to receiving no more than $5,000 a day for working on boards of pharmaceutical or biotechnology companies, reports the New York Times. Partners HealthCare forbidding employees from accepting speaker fees from drug companies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.